Regenxbio RGNX
NASDAQ RGNX
$6.68 -0.49 (-6.83%)
At close: Oct 23, 2026 · 4:00 PM EDT

Regenxbio (RGNX) Net Preferred Shares Issued and Repurchased (2015)

Updated

Regenxbio's Net Preferred Shares Issued and Repurchased came in at $1.97 million for FY2013.

Analysis

Regenxbio (RGNX) Net Preferred Shares Issued and Repurchased (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Regenxbio 356.27 Mn -576.82 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 68.00 Mn
Mar 31, 2015 26.02 Mn
API Access

Regenxbio Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=RGNX&period=max&api_key=YOUR_API_KEY